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CytokineMounting evidence has established a role for chronic inﬂammation in the development of obesity-induced
insulin resistance, as genetic ablation of pro-inﬂammatory cytokines and chemokines elevated in obesity
improves insulin signaling in vitro and in vivo. Recent evidence further highlights interleukin (IL)-12 family
cytokines as prospective inﬂammatory mediators linking obesity to insulin resistance. In this study, we
present empirical evidence demonstrating that IL-12 family related genes are expressed and regulated in
insulin-responsive tissues under conditions of obesity. First, we report that respective mRNAs for each of
the known members of this cytokine family are expressed within detectable ranges in WAT, skeletal muscle,
liver and heart. Second, we show that these cytokines and their cognate receptors are divergently regulated
with genetic obesity in a tissue-speciﬁc manner. Third, we demonstrate that select IL-12 family cytokines
are regulated in WAT in a manner that is dependent on the developmental stage of obesity as well as the in-
ﬂammatory progression associated with obesity. Fourth, we report that respective mRNAs for IL-12 cytokines
and receptors are also expressed and divergently regulated in cultured adipocytes under conditions of inﬂam-
matory stress. To our knowledge, this report is the ﬁrst study to systemically evaluated mRNA expression of
all IL-12 family cytokines and receptors in any tissue under conditions of obesity highlighting select family
members as potential mediators linking excess nutrient intake to metabolic diseases such as insulin resistance,
diabetes and heart disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Obesity and diabetes mellitus are major public health concerns
worldwide leading to neuropathies, cardiovascular disease, hyperten-
sion, and stroke [6,17]. Mounting evidence has established a role
for chronic, low-grade inﬂammation in the development of obesity-
induced insulin resistance [14,20,28]. Several investigations have
shown that chemokine and cytokine levels are increased during obesi-
ty and that ablation of these pro-inﬂammatory molecules improves
insulin signaling in insulin-responsive tissues [33,40]. While WAT
is recognized as a key site of cytokine expression in obesity, other
insulin-responsive tissues, such as skeletal muscle and liver also expe-
rience increased inﬂammation in the obese state [1,4,5,13,14,32].
Therefore, obesity induces an insulin-resistant state in these tissues,
resulting in an imbalance of systemic glucose homeostasis that contrib-
utes to the pathological metabolic disorders associated with obesity.
While it is nowwell recognized that an array of inﬂammatory cytokines
and chemokines are increased in obese tissues, extensive studies are799 (RFM).
nﬂicts of interest.
nsboro, Greensboro, NC 27402,
rights reserved.underway to identify inﬂammatory mediators that contribute to in-
ﬂammation and ultimately chronic diseases such as type 2 diabetes.
Recent evidence highlights IL-12 family cytokines as prospective
regulators linking obesity to insulin resistance. While plasma levels
of select IL-12 family members are elevated with obesity, diabetes,
and metabolic syndrome [37,41–43], their cellular origin has not
been fully determined. IL-12 family cytokines are mostly expressed
in antigen-presenting cells and play critical roles during inﬂammatory
stress. The members of the IL-12 family are heterodimeric proteins
consisting of an alpha chain and a beta chain (Fig. 1). The alpha chains
consist of p19, p28, or p35 that share structural homology with IL-6,
whereas the beta chains, p40 or Epstein-Barr virus-induced gene 3
(EBI3), shares homology with soluble cytokine receptor chains, such
as IL-6Rα [12,29]. Dimerization of speciﬁc alpha chain and beta
chain subunits form the four known family members including IL-12
(i.e., p35 and p40), IL-23 (i.e., p19 and p40), IL-27 (i.e., p28 and
EBI3), and the newly identiﬁed IL-35 (i.e., p35 and EBI3). Each cyto-
kine signals through unique heterodimeric receptors that are com-
posed of combinations of IL-12Rβ1, IL-12Rβ2, IL-23R, gp130, and
WSX-1 subunits [7]. Current evidence suggests that alpha and beta
subunits dimerize within the cell to produce and secrete biologically
active cytokines known to play roles in linking innate resistance
and adaptive immunity [39]. Although the pairing between cytokine
subunits and receptors is conserved, the origin, activity, and kinetic
expression are cell-type and condition-speciﬁc.
Fig. 1. Schematic of IL-12 family cytokines and receptors. IL-12 family cytokines are heterodimers composed of shared alpha and beta chain subunits that dimerize to form IL-27,
IL-35, IL-12, and IL-23. Each cytokine signals through unique heterodimeric cell surface receptors. Receptor composition for the newest member of the family, IL-35, has not been
determined.
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family cytokines and their cognate receptors in response to obesity
in WAT, liver, skeletal muscle, and heart, as these insulin-responsive
tissues centrally regulate glucose homeostasis and vascular function
[13,19,24]. As we report that IL-12 family expression is most abun-
dant in WAT, this report further investigated the developmental
role of obesity on IL-12 family regulation in WAT as well as the regu-
lation of these cytokines and receptors in cultured adipocytes. This
report highlights select IL-12 family members as potential mediators
linking excess nutrient intake to metabolic diseases such as insulin
resistance, diabetes and heart disease.
2. Materials and methods
2.1. Materials
Dulbecco's Modiﬁed Eagle's Medium (DMEM), calf bovine serum
(CS) and recombinant murine tumor necrosis factor alpha (TNFα)
were purchased from Invitrogen. Fetal bovine serum (FBS)was obtained
from HyClone.
2.2. Mice and experimental diets
Animals used for this study included genetically obese male
B6.V-Lepob/J (B6-ob/ob) mice and their lean littermates as well as
C57BL/6J mice rendered obese by dietary intervention and their lean
controls. All mice were housed and treated by the supplier (Jackson
Laboratories) until shipment 1 week prior to tissue harvest. B6-ob/ob
mice and lean littermates were purchased for experimentation at
6 weeks and 10 weeks of age and given free access to standard labora-
tory chow diet. C57BL/6J mice subjected to diet-induced obesity (DIO)
were fed a high fat diet (HFD) consisting of 60% kcal from fat (Research
Diets Inc., D12492) from 6 weeks of age. Lean C57BL/6J control mice
were fed a control diet consisting of 10% kcal from fat (Research Diet
Inc., D12450B) from 6 weeks of age. Both diets contained 10% kcal
from protein with the balance in caloric intake provided by differences
in carbohydrate content. Mice receiving both diets were given free
access to food and shipped for experimentation at 18 weeks and
24 weeks of age. All animals were euthanized by CO2 gas asphyxiation
and epididymal WAT, liver, calf skeletal muscle, and ventricular heart
tissue collected and processed for total RNA isolation. Animal care and
use was in compliancewith the Institute of Laboratory Animal Research
Guide for the Care and Use of Laboratory Animals and approved by
the Institutional Animal Use and Care Committee. All animal studies
were conducted with 4–7 mice in each group.
2.3. Cell culture
The murine 3T3-L1 cell line was purchased from Howard Green,
Harvard Medical School [10]. Cells were propagated in DMEM
supplemented with 10% CS until reaching growth arrest as previouslydescribed [30]. At 2 days post-conﬂuence, growth medium was re-
placed with DMEM supplemented with 10% FBS, 0.5 mM 1-methy-
3-isobutylxanthane, 1 μM dexamethasone, and 1.7 μM insulin (MDI)
for 2 days. Subsequently, cells were cultured in DMEM supplemented
only with 10% FBS over the following six days as preadipocytes (PAs)
differentiated into functionally and morphologically mature adipo-
cytes (ADs). Adipocyte experiments described herein were conducted
at the extremes of this process where undifferentiated PAs were com-
pared to mature ADs. For reference, experiments were also conducted
in conﬂuent RAW 264.7 macrophage cells (gift from Mark Brown,
Wake Forest University School of Medicine) under basal conditions
with culture medium containing DMEM supplemented with 10% CS.
All cell experiments in this study were performed in duplicate and
repeated 2–3 times to validate results and ensure reliability.
2.4. Real-time RT-PCR
For animal studies, total RNA was isolated from aforementioned
insulin-responsive tissues utilizing Trizol reagent (Invitrogen) according
to themanufacturer's protocol and further processed as described by the
Qiagen RNA clean-up protocol. For cell studies, total RNA was extracted
and genomic DNA contamination was removed using the RNeasy Plus
Mini Kit (Qiagen), according to themanufacturer's protocol. RNA quality
was assessed via integrity gels and quantiﬁedwith aNanodropND-1000
spectrophotometer. Total RNA was reverse-transcribed to cDNA in a
10 μl reaction volume using Applied Biosystems (ABI) High Capacity
cDNA Reverse Transcription kit and the Gene Amp PCR System 9700
Thermal cycler following manufacturer's protocol.
PCR ampliﬁcationwas run utilizing the ABI 7500 Fast Systemand the
manufacturer's Fast Protocol. All TaqMan primer probes used in this
study were also purchased from ABI. Data were recorded and analyzed
with ABI Sequence Detector Software and graphs visualized with
SigmaPlot software. All data were presented as mean±standard error
of the mean (SEM) and representative of duplicate determinations.
Data were normalized to 18S and presented as relative differences
using the 2-ΔΔCT method as previously described [11,26]. Statistical
analyses were conducted using SPSS v18. Differences in gene expres-
sion between lean and obese animals as well as between PAs and ADs
were determined via student's t-test where a p-value of b0.05 was con-
sidered signiﬁcant. Other data were analyzed using analysis of variance
(ANOVA), with Tukey's post-hoc analysis used when the p-value for the
respective parameter was statistically signiﬁcant (pb0.05).
3. Results
3.1. Relative IL-12 family cytokine and receptor gene expression across
insulin-responsive tissues from wildtype C57BL/6J mice
As recent evidence has demonstrated a potential role for IL-12
family cytokines in obesity-induced IR [41,43], we began these studies
by determining the gene expression proﬁle of all IL-12 family genes
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old wildtype C57BL/6J mice given ad libitum access to standard
chow. As illustrated in Table 1, all cytokine and receptor subunits
were easily detectable in WAT with average Ct threshold values
ranging from 21 to 32 cycles. As a point of reference, WAT Ct values
varied by four cycles (i.e., 16-fold) or less from RAW 264.7 macro-
phage cells under basal conditions based on equal total RNA input
of 100 ng/reaction. For comparison across tissues, relative mRNA
abundance of each cytokine and receptor subunit in each tissue was
normalized to 18S and expressed as fold-difference relative to WAT.
As illustrated in Fig. 2, all 10 genes were detectable in all four tissues,
but to varying degrees suggesting tissue-speciﬁc modes of regulation
under normal lean conditions. Comparison between tissues also
highlighted that 4 of 5 cytokine subunits and 4 of 5 receptor subunits
were expressed in WAT at a level that was greater than or equal to
other tissues with the exception of p35 that was ~90-fold more abun-
dant in skeletal muscle and IL-12Rβ1 that was ~3-fold more abundant
in liver. Comparable patterns of gene expression were also noted for
EBI3, p40, p19, WSX-1 where relative mRNA was most abundant in
WAT and least abundant in skeletal muscle as well as for IL-12Rβ2
and IL-23R that were markedly more abundant in WAT relative to all
other tissues examined.
3.2. Impact of obesity on IL-12 family gene expression within insulin-
responsive tissues comparing lean and genetically obese mice
While IL-12 family cytokines are well established in critical roles
regarding inﬂammatory stress in antigen-presenting immune cells,
the role of these cytokines regarding obesity-induced inﬂammation
in metabolically active tissues remains poorly deﬁned. As an initial
step toward this goal, we examined the impact of genetic obesity
on the expression of IL-12 family cytokines and receptors in each of
the insulin-responsive tissues discussed above. While obesity is
known to promote inﬂammation in WAT, skeletal muscle and liver,
we purposely included heart tissue in these determinations as an
insulin-responsive, metabolically active tissue that has no known
role regarding the chronic inﬂammation that is commonly associated
with excessive weight gain. For these determinations, we compared
10 week old lean, wildtype mice to obese, leptin-deﬁcient (ob/ob)
mice given ad libitum access to standard chow. Using this geneticTable 1
IL-12 family cytokine/receptor and inﬂammatory/adipocyte genes analyzed in this study.
Name
IL-12 cytokines IL-27 IL-35 IL-12 IL-23
p28 ●
EBI3 ● ●
p35 ● ●
p40 ● ●
p19 ●
IL-12 receptors
WSX-1 ●
gp130 ●
IL-12Rβ2 ●
IL-12Rβ1 ● ●
IL-23R ●
Adipocyte and inﬂammatory genes
Adipsin
MCP-1
IL-6
TNFα
Reference gene
18S
ND = non-detectable threshold cycle.
a Average threshold cycle (CT) for white adipose tissue (WAT) from 10 week old, lean C5
b Average threshold cycle (CT) for conﬂuent murine RAW 264.7 macrophage cells.
c Average threshold cycle (CT) for conﬂuent murine 3T3-L1 preadipocytes (PA).
d Average threshold cycle (CT) for mature day 8 murine 3T3-L1 adipocytes (AD).model of obesity, we determined relative mRNA abundance for each
cytokine and receptor where obese values were expressed as fold-
differences relative to lean values within each tissue. As shown in
Fig. 3, WAT and skeletal muscle presented with similar proﬁles of
gene expression where p28, EBI3 and p40 were signiﬁcantly induced
in obese relative to lean tissue. This is in striking contrast to heart
tissue where the same three cytokine subunits and their cognate re-
ceptors were signiﬁcantly suppressed with obesity. As an important
target of inﬂammatory cytokine action regarding insulin-sensitivity,
it was also interesting to note that skeletal muscle presented with the
greatest obesity-induced increases in receptor subunit gene expression.
3.3. Relative IL-12 family cytokine gene expression in WAT during the
progressive development of genetic and diet-induced obesity
It is well recognized that WAT is a key site regarding the origin of
obesity-induced inﬂammation that leads to systemic IR [13,24]. As
data presented above demonstrated that IL-12 family cytokines
were abundantly expressed inWAT and induced with genetic obesity,
we next examined the progressive development of obesity on IL-12
family cytokine expression in WAT using two distinct stages of devel-
opment in two distinct models of obesity (genetic vs. diet-induced
obesity). According to the supplier, B6-ob/ob mice exhibit adipocyte
hyperplasia with ensuing obesity notable at 1 month of age and tran-
sient glucose intolerance that begins at ~6 weeks of age and subsides
after ~12 weeks of age. Thus, experiments were conducted with
6 week and 10 week old B6-ob/ob mice and wildtype littermates,
representing sequential, progressive stages of obesity with developing
obesity-related metabolic disorders. For diet-induced obesity (DIO),
C57BL/6J male mice were fed a high fat diet (HFD; 60% kcal from fat)
by the supplier starting at 6 weeks of age. Control littermates were
fed a control diet containing 10% kcal from fat. Studies were conducted
at 18 weeks and 24 weeks of age, representing 12 weeks and 18 weeks
of dietary intervention, respectively. Progressive stages of obesity
development in both models were arbitrarily designated as stage I
and stage II. Using these distinctmodels of obesity, relativemRNAabun-
dance for each IL-12 family cytokine in WAT was normalized to 18S
and expressed as fold-differences relative to lean controls. To charac-
terize the development of obesity-induced inﬂammation, we included
the cytokines, TNFα and IL-6, as well as the chemokine, monocyteAccession ABI number WAT
CTa
RAW
CTb
PA
CTc
AD
CTd
NM_145636 Mm00461164_m1 32 28 34 28
NM_015766 Mm00469294_m1 28 24 32 34
NM_008351 Mm01208555_m1 32 35 36 35
NM_008352 Mm00434174_m1 30 33 36 36
NM_031252 Mm00518984_m1 27 25 30 31
NM_016671 Mm00497259_m1 28 34 33 36
NM_010560 Mm00439665_m1 21 25 22 24
NM_008354 Mm00434200_m1 29 33 35 36
NM_008353 Mm00434189_m1 29 29 30 34
NM_144548 Mm00519943_m1 28 32 33 36
NM_013456 Mm00442664_m1 17 ND 35 14
NM_011333 Mm00441242_m1 27 17 23 27
NM_031168 Mm99999064_m1 32 26 29 30
NM_013693 Mm99999068_m1 29 21 34 35
X03205 4342930E 9 7 7 8
7BL/6J mice.
Fig. 2. Relative IL-12 family cytokine and receptor gene expression across insulin-responsive tissues from lean C57BL/6J mice. Relative mRNA abundance of ligand (A) and receptor
(B) subunits was determined by qRT-PCR from total RNA extracted from epididymal white adipose tissue (WAT), liver, calf skeletal muscle, and heart of 10 week old lean C57BL/6J
mice. Data were normalized to 18S and expressed as fold differences relative to WAT. Statistical differences were determined by ANOVA, with Tukey's post-hoc analysis performed
when the p-value for the respective parameter was statistically signiﬁcant (pb0.05).
14 H. Nam et al. / Biochimica et Biophysica Acta 1832 (2013) 11–19
Fig. 3. Relative IL-12 family cytokine and receptor gene expression within insulin-responsive tissues comparing lean and obese Ob/Ob mice. Relative mRNA abundance of ligand
(A) and receptor (B) subunits was determined by qRT-PCR from total RNA extracted from white adipose tissue (WAT), liver, skeletal muscle and heart of 10 week old lean
and leptin-deﬁcient (ob/ob) mice. Data were normalized to 18S and relative abundance determined for each cytokine and receptor where obese values were expressed
as fold-differences relative to lean within each tissue. Differences in gene expression between lean and obese animals were determined via student's t-test where a p-value
of b0.05 was considered signiﬁcant.
15H. Nam et al. / Biochimica et Biophysica Acta 1832 (2013) 11–19chemotactic protein-1 (MCP-1). Each of these inﬂammatory markers is
known to play central roles in obesity-induced inﬂammation where
WAT is a major site of expression. Adipsin was also included as a
biochemical marker of obesity as others have documented a marked
suppression of this gene in WAT of obese versus lean animals [8,22].
As illustrated in Fig. 4, mRNA expression of all IL-12 family cyto-
kines showed no marked difference with stage I genetic (ob/ob)
obesity where only MCP-1 mRNA was elevated. This was consistent
with other inﬂammatory genes where TNFα and IL-6 were also notsigniﬁcantly different between lean and ob/ob mice at this stage of
development. In contrast, relative mRNA abundance of p28, EBI3,
and p40 was signiﬁcantly induced in stage II ob/ob mice, paralleling
the induction of TNFα and IL-6 mRNA expression. Although not
apparent as illustrated, adipsin mRNA abundance progressively de-
creased as ob/ob mice transitioned from stage I (~40-fold reduction)
to stage II (~80-fold reduction) obesity where the percent difference
in body weight (data not shown) between lean and obese mice in-
creased from 67% to 83%. Interestingly, the same three IL-12 cytokines
Fig. 4. Relative IL-12 family cytokine gene expression in WAT during the progressive development of genetic and diet-induced obesity. Relative mRNA abundance of IL-12 family
cytokine (A) and inﬂammatory genes (B) was determined by qRT-PCR from total RNA extracted from white adipose tissue (WAT) at progressive stages of obesity from ob/ob mice
as well as mice subject to diet-induced obesity (DIO). Data were normalized to 18S and relative abundance determined for each cytokine where obese values were expressed as
fold-differences relative to lean within each group. Differences in gene expression between lean and obese animals were determined via student's t-test where a p-value of
b0.05 was considered signiﬁcant.
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ﬂammatory gene expression. While EBI3 and p40 were elevated in
stage I DIO with increased TNFα expression, p28 was not increased
until the mice reached stage II of development that presented with
a greater increase in TNFα expression. This extended time of high
fat feeding was also characterized by a progressive decrease in
adipsin expression as well as an increase in percent difference in
body weight from 13% to 26%. Collectively, these data demonstrated
that p28, EBI-3 and p40 are induced at the level of gene expressionin WAT concurrent with the progressive development of inﬂamma-
tion associated with sequential stages of obesity development.
3.4. Relative IL-12 family cytokine and receptor gene expression in
murine 3T3-L1 adipocytes under conditions of inﬂammatory stress
The progression of obesity involves enlargement of adipose tissue
mass through an increase in size and number of adipocytes as well as
recruitment of macrophages and other immune cells that contribute
Fig. 5. Relative IL-12 family cytokine and receptor gene expression in murine 3T3-L1 adipocytes under conditions of inﬂammatory stress. Relative mRNA abundance of cytokines
and receptors was determined by qRT-PCR from total RNA extracted over time following 100 pM TNFα stimulation from undifferentiated preadipocytes (A) and mature adipocytes
(B). Data were normalized to 18S and relative abundance determined for each phenotype where stimulated values were expressed as fold-differences relative to untreated (UT)
controls. Differences in gene expression were determined via student's t-test where a p-value of b0.05 was considered signiﬁcant.
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pose tissue. To investigate a potential role for adipocytes in IL-12 family
gene expression as observed above forWAT, we next examined relative
mRNA abundance for each cytokine and receptor subunit in 3T3-L1mu-
rine undifferentiated preadipocytes (PA) and mature adipocytes (AD)
overtime following stimulation with 100 pM TNFα. This concentration
of TNFα was chosen as it approximated the ED50 for induction of
MAPK and NF-kB signaling pathways that mediate inﬂammatory gene
expression (data not shown). Both cell populations were rendered
quiescent either by density arrest for PAs or by terminal growth arrest
following 8 days of differentiation in ADs minimizing any inﬂuence of
cell proliferation on gene expression. Data presented in Fig. 5 represent
relative mRNA abundance at the time point of peak induction following
TNFα stimulation for each gene, where mRNA was normalized to 18S
and expressed as fold-differences relative to untreated (UT) controls.
As illustrated in Fig. 5, TNFα stimulation signiﬁcantly increased mRNA
abundance for all ﬁve IL-12 cytokines from 20–50 fold in PAs, where
peak induction was observed at 2 h for p19, 4 h for p28 and p40 and
12 h for EBI-3 and p35. While similar kinetics of induction were
observed in ADs, two notable differences were observed regarding the
magnitude of induction. First, p40 was induced ~10-fold greater in
ADs versus PAs and second, p28 was completely refractory to TNFα
stimulation in ADs. In contrast to the inducible nature of IL-12 family
cytokines, IL-12b1 and IL-23R were the only two receptors induced
following TNFα stimulation where peak induction was observed
at 6 h post-stimulation. These data demonstrated 1) that all IL-12
cytokines and receptors were expressed in this adipocyte cell line that
was devoid of immune cells such as monocytes and macrophages,
2) that IL-12 cytokines were collectively more inducible than receptors,
and 3) that select cytokines (i.e., p28 and p40) presented with ex-
pression patterns that were dependent on the extent of adipocyte
differentiation.
4. Discussion
To our knowledge, this report is the ﬁrst study to systemically
evaluatedmRNA expression of all IL-12 family cytokines and receptorsin any tissue under conditions of obesity. Albeit limited to mRNA
assessment, there is utility in observing the totality of all knownmem-
bers of this cytokine family in tissues and cell types that have not been
reported previously. While much work has focused on activated
inﬂammatory cells such as monocytes, macrophages, and dendritic
cells [39], data presented here demonstrate that IL-12 family cyto-
kines are also expressed and regulated at the mRNA level in
insulin-responsive tissues with obesity-induced inﬂammation. While
we did not examine activated immune cells, we do show that mRNA
abundancewithinWAT from leanmice is comparable to that observed
for quiescent macrophages. As most tissues are composed of multiple
cell types that may include classic immune cells, it is plausible that ob-
served changes in tissue gene expression presented in this report may
reﬂect to some degree, changes in mRNA abundance of inﬁltrating
macrophages. This could be particularly relevant for WAT as macro-
phage inﬁltration into this tissue during the progressive development
of obesity has been widely observed [18,34,36,44]. On the other
hand, we also present data demonstrating that genes encoding these
cytokines and their receptors are expressed and regulated in an
established murine adipocyte cell line that is devoid of macrophages
or other classic inﬂammatory cells. As chronic inﬂammation is now con-
sidered an important element of the pathogenic mechanisms linking
obesity and metabolic diseases, a potential role for IL-12 family cyto-
kines seems plausible and should be addressed in future investigations.
It is generally well-established that production of biologically
active IL-12 family cytokines depends on coordinate expression of
genes encoding both heterodimeric partners in the same cell [39].
With this criterion in mind, our data highlight the expression of
IL-27 as both p28 and EBI-3 genes were signiﬁcantly elevated in
WAT of genetic- and diet-induced obese mice, paralleling the onset
of obesity-induced inﬂammation. We also demonstrate that both
IL-27 genes were inducible in 3T3-L1 preadipocytes under conditions
of inﬂammatory stress, but not in mature adipocytes as p28 becomes
refractory to TNFα with differentiation. While the refractory nature
of p28 that accompanies differentiation might suggests that IL-27
only plays a role in preadipocytes, we have also determined that con-
stitutive, basal levels of p28 mRNA are elevated with differentiation
18 H. Nam et al. / Biochimica et Biophysica Acta 1832 (2013) 11–19and that IL-27 is secreted from both PAs as well as ADs under condi-
tions of inﬂammatory stress (data not shown). While others have
shown that p28 and EBI3 can be expressed independently in some
cell types [27] and differentially regulated in response to various
stimuli [35], the coordinate regulation of IL-27 heterodimeric gene
expression and protein secretion highlight the possibility of a func-
tional role for this cytokine in the sequelae of inﬂammatorymediators
originating in WAT and linking obesity to metabolic diseases.
Historic literature identiﬁed IL-27 as a pro-inﬂammatory cytokine
that is secreted mainly by macrophages and dendritic cells in
response to microbial infection where it plays a role in autoimmune
disease and host defense against infection. Dual functions for this
cytokine have been reported more recently as IL-27 has also been
shown to have anti-inﬂammatory properties in several murine
diseasemodels [21,23,48].While underlying anti-inﬂammatorymecha-
nisms are not yet clear, it has been observed that IL-27 can suppress
inﬂammatory cytokines, such as TNFα, IL-6, and IL-17 [2,16,38,47].
Moreover, anti-inﬂammatory and anti-viral roles of IL-27 in cardiac
muscle have been reported using mice with a cardiac-speciﬁc deletion
of IL-27 receptor subunit gp130 [46]. We bring attention to this here
as data presented in our study also demonstrate that both heterodimers
for IL-27 are suppressed in cardiac tissue with obesity. Thus, it is also
plausible that obesity-induced suppression of IL-27 in the heart may
exacerbate the inﬂammatory response by inhibiting IL-27 suppression
of TNFα and IL-6, two major players in vascular endothelial inﬂamma-
tion and atherosclerosis [15,25]. While this premise is presented hypo-
thetically, it does support the notion that biologically relevant changes
in IL-12 family gene expression could include those where genes are
suppressed as well as those where genes are activated.
There is also evidence demonstrating that it is not inducibility
in itself, but rather the magnitude of coordinated gene expression
that dictates IL-12 family cytokine synthesis. Consistent with this
premise, others have reported that alpha chains subunits (i.e., p35,
p19, p28), are often constitutively expressed, whereas beta chain
subunit (i.e., p40 and EBI-3) expression is highly regulatedwith exter-
nal stimuli with synthesis of IL-12 family cytokines limited by the
magnitude of constitutively expressed of alpha chain gene subunits
[3,9,31,45]. In this regard, data presented in this report show that
while p40 and EBI-3 were both induced with genetic obesity in skeletal
muscle, p35 was not. However, we also demonstrate that constitutive
expression of p35 was signiﬁcantly elevated in skeletal muscle in lean
mice relative to other tissues suggesting that the induction of p40 or
EBI-3 may support the synthesis of IL-12 or IL-35, respectively.
In summary, this study provides the ﬁrst comprehensive and sys-
tematic gene analysis of the IL-12 family cytokines under conditions
of obesity in major insulin responsive tissues involved in metabolic
homeostasis.While this study presents novel data regarding divergent
regulation of gene expression in tissues and cell types not reported
previously, the outcome should serve only as a platform for future
investigations whereby cytokine secretion and functional activity
can be evaluated for each individual IL-12 family member in a cell-,
tissue-, and condition-speciﬁc manner.
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